Effect of triglyceride oil on the treatment of neonatal jaundice

Evaluation of the effect of oral Medium-Chain Triglyceride oil in the treatment of hyperbillirubinemia in term neonates ?

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001162N26

Enrollment

Registered

2020-11-21

Start date

2019-07-23

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperbillirubinemia in term neonates ?. Neonatal jaundice, unspecified

Interventions

Intervention 1: interventional group will receive Medium-Chain Triglycerides (Nutricia) orally 3 cc / kg as a single dose. Intervention 2: control group will receive placebo(distilled water) orally

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: gestational age more than 37 weeks Birth weight more than 2500 grams Indication of phototherapy

Exclusion criteria

Exclusion criteria: Congenital anomaly infection Gastrointestinal obstruction and cholestasis Heart failure blood exchange Renal failure blood group or Rh incompatibility Low Apgar Subgaleal hemorrhage Cephal hematoma

Design outcomes

Primary

Measure	Time frame
Indirect serum bilirubin levels. Timepoint: On admission and at 24, 48, 72 hours later and if necessary the following days. Method of measurement: skin bilirubin meter and blood sample (if necessary).	—

Secondary

Measure	Time frame
Daily weight information. Timepoint: Hospitalization. Method of measurement: scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEzzat Khodashenas

Mashhad University of Medical Sciences

khodashenase@mums.ac.ir+98 51 3852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026